The Research Institute of the McGill University Health Centre

Montreal, Quebec H4A3J1

4 studies enrolling now · 10 studies all time

What they study most

Angelman Syndrome, BK Virus Infection, Carcinoma, Non-Small-Cell Lung, Crohn's Disease, Drug Resistant Epilepsy, Epilepsy, Hearing Loss, Hemophilia B, Leiomyosarcoma, Liposarcoma, Non-muscle Invasive Bladder Cancer, Retroperitoneal Sarcoma

Studies at this site

• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) — Recruiting now
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease — Recruiting now
• Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma — Recruiting now
• Long-term Extension of GTX-102 in Angelman Syndrome — Enrolling by invitation
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• Multi-Center Study on Performance of the Ponto Implant System Using Minimally Invasive Ponto Surgery (in Adult Patients) — Completed
• Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. — Completed
• A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients — Completed